位置:首页 > 蛋白库 > CD14_BOVIN
CD14_BOVIN
ID   CD14_BOVIN              Reviewed;         373 AA.
AC   Q95122; A8DBS7; Q9TVA7;
DT   15-DEC-1998, integrated into UniProtKB/Swiss-Prot.
DT   15-DEC-1998, sequence version 2.
DT   03-AUG-2022, entry version 127.
DE   RecName: Full=Monocyte differentiation antigen CD14;
DE   AltName: Full=Myeloid cell-specific leucine-rich glycoprotein;
DE   AltName: CD_antigen=CD14;
DE   Flags: Precursor;
GN   Name=CD14;
OS   Bos taurus (Bovine).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Laurasiatheria; Artiodactyla; Ruminantia; Pecora; Bovidae;
OC   Bovinae; Bos.
OX   NCBI_TaxID=9913;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], TISSUE SPECIFICITY, AND INDUCTION BY
RP   BACTERIAL LIPOPOLYSACCHARIDE.
RC   STRAIN=Holstein;
RX   PubMed=9300371; DOI=10.1292/jvms.59.715;
RA   Ikeda A., Takata M., Taniguchi T., Sekikawa K.;
RT   "Molecular cloning of bovine CD14 gene.";
RL   J. Vet. Med. Sci. 59:715-719(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Holstein-Friesian;
RA   Filipp D., Julius M.J.;
RT   "Cloning of cDNA for bovine CD14.";
RL   Submitted (APR-1999) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Ibeagha-Awemu E.M., Lee J.-W., Ibeagha A.E., Zhao X.;
RT   "Genetic mutations in the CD14 gene of cattle and relationship with the
RT   percentage of surface CD14-bound monocytes and neutrophils in healthy dairy
RT   cows.";
RL   Submitted (SEP-2007) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 179-278, AND TISSUE SPECIFICITY.
RX   PubMed=8643545; DOI=10.1073/pnas.93.10.5156;
RA   Diamond G., Russell J.P., Bevins C.L.;
RT   "Inducible expression of an antibiotic peptide gene in lipopolysaccharide-
RT   challenged tracheal epithelial cells.";
RL   Proc. Natl. Acad. Sci. U.S.A. 93:5156-5160(1996).
CC   -!- FUNCTION: Coreceptor for bacterial lipopolysaccharide. In concert with
CC       LBP, binds to monomeric lipopolysaccharide and delivers it to the
CC       LY96/TLR4 complex, thereby mediating the innate immune response to
CC       bacterial lipopolysaccharide (LPS). Acts via MyD88, TIRAP and TRAF6,
CC       leading to NF-kappa-B activation, cytokine secretion and the
CC       inflammatory response. Acts as a coreceptor for TLR2:TLR6 heterodimer
CC       in response to diacylated lipopeptides and for TLR2:TLR1 heterodimer in
CC       response to triacylated lipopeptides, these clusters trigger signaling
CC       from the cell surface and subsequently are targeted to the Golgi in a
CC       lipid-raft dependent pathway. Binds electronegative LDL (LDL(-)) and
CC       mediates the cytokine release induced by LDL(-) (By similarity).
CC       {ECO:0000250|UniProtKB:P08571, ECO:0000250|UniProtKB:P10810}.
CC   -!- SUBUNIT: Belongs to the lipopolysaccharide (LPS) receptor, a multi-
CC       protein complex containing at least CD14, LY96 and TLR4. Interacts with
CC       LPS-bound LPB. Interacts with LPAR1. Interacts with the TLR2:TLR6 or
CC       TLR2:TLR1 heterodimers; upon interaction with ligands such as
CC       diacylated lipopeptides and triacylated lipopeptides, respectively.
CC       Interacts with MYO18A. Interacts with FSTL1.
CC       {ECO:0000250|UniProtKB:P08571, ECO:0000250|UniProtKB:P10810}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:P08571};
CC       Lipid-anchor, GPI-anchor {ECO:0000250|UniProtKB:P08571}. Secreted
CC       {ECO:0000250|UniProtKB:P08571}. Membrane raft
CC       {ECO:0000250|UniProtKB:P08571}. Golgi apparatus
CC       {ECO:0000250|UniProtKB:P08571}. Note=Soluble, secreted forms seem to
CC       exist. They may arise by cleavage of the GPI anchor.
CC       {ECO:0000250|UniProtKB:P08571}.
CC   -!- TISSUE SPECIFICITY: Detected in lung (PubMed:9300371, PubMed:8643545).
CC       Detected in brain and kidney (PubMed:9300371). Detected in trachea and
CC       bone marrow (PubMed:8643545). {ECO:0000269|PubMed:8643545,
CC       ECO:0000269|PubMed:9300371}.
CC   -!- INDUCTION: Up-regulated in peripheral blood monocytes exposed to
CC       bacterial lipopolysaccharide (LPS). {ECO:0000269|PubMed:9300371}.
CC   -!- DOMAIN: The C-terminal leucine-rich repeat (LRR) region is required for
CC       responses to smooth LPS. {ECO:0000250|UniProtKB:P10810}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; D84509; BAA21517.1; -; Genomic_DNA.
DR   EMBL; AF141313; AAD32215.1; -; mRNA.
DR   EMBL; EU148609; ABV68569.1; -; Genomic_DNA.
DR   EMBL; EU148610; ABV68570.1; -; Genomic_DNA.
DR   EMBL; U48356; AAB07861.1; -; mRNA.
DR   RefSeq; NP_776433.1; NM_174008.1.
DR   AlphaFoldDB; Q95122; -.
DR   SMR; Q95122; -.
DR   STRING; 9913.ENSBTAP00000020009; -.
DR   PaxDb; Q95122; -.
DR   PeptideAtlas; Q95122; -.
DR   PRIDE; Q95122; -.
DR   GeneID; 281048; -.
DR   KEGG; bta:281048; -.
DR   CTD; 929; -.
DR   eggNOG; ENOG502SNYQ; Eukaryota.
DR   InParanoid; Q95122; -.
DR   Proteomes; UP000009136; Unplaced.
DR   GO; GO:0031362; C:anchored component of external side of plasma membrane; ISS:UniProtKB.
DR   GO; GO:0009897; C:external side of plasma membrane; ISS:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0005794; C:Golgi apparatus; ISS:UniProtKB.
DR   GO; GO:0046696; C:lipopolysaccharide receptor complex; ISS:UniProtKB.
DR   GO; GO:0045121; C:membrane raft; ISS:UniProtKB.
DR   GO; GO:0001530; F:lipopolysaccharide binding; IBA:GO_Central.
DR   GO; GO:0071726; P:cellular response to diacyl bacterial lipopeptide; ISS:UniProtKB.
DR   GO; GO:0071222; P:cellular response to lipopolysaccharide; ISS:UniProtKB.
DR   GO; GO:0071727; P:cellular response to triacyl bacterial lipopeptide; ISS:UniProtKB.
DR   GO; GO:0006954; P:inflammatory response; IBA:GO_Central.
DR   GO; GO:0045087; P:innate immune response; IEA:UniProtKB-KW.
DR   GO; GO:0031663; P:lipopolysaccharide-mediated signaling pathway; IBA:GO_Central.
DR   GO; GO:0032729; P:positive regulation of interferon-gamma production; ISS:UniProtKB.
DR   GO; GO:0031666; P:positive regulation of lipopolysaccharide-mediated signaling pathway; ISS:UniProtKB.
DR   GO; GO:1901224; P:positive regulation of NIK/NF-kappaB signaling; IBA:GO_Central.
DR   GO; GO:0034145; P:positive regulation of toll-like receptor 4 signaling pathway; ISS:UniProtKB.
DR   GO; GO:0032760; P:positive regulation of tumor necrosis factor production; ISS:UniProtKB.
DR   GO; GO:0032481; P:positive regulation of type I interferon production; IBA:GO_Central.
DR   GO; GO:0009617; P:response to bacterium; ISS:UniProtKB.
DR   GO; GO:0034142; P:toll-like receptor 4 signaling pathway; IBA:GO_Central.
DR   Gene3D; 3.80.10.10; -; 1.
DR   InterPro; IPR001611; Leu-rich_rpt.
DR   InterPro; IPR032675; LRR_dom_sf.
DR   InterPro; IPR016337; Monocyte_diff_Ag_CD14.
DR   PANTHER; PTHR10630; PTHR10630; 1.
DR   Pfam; PF13516; LRR_6; 1.
DR   PIRSF; PIRSF002017; CD14; 1.
DR   PROSITE; PS51450; LRR; 3.
PE   2: Evidence at transcript level;
KW   Cell membrane; Disulfide bond; Glycoprotein; Golgi apparatus; GPI-anchor;
KW   Immunity; Inflammatory response; Innate immunity; Leucine-rich repeat;
KW   Lipoprotein; Membrane; Reference proteome; Repeat; Secreted; Signal.
FT   SIGNAL          1..20
FT                   /evidence="ECO:0000255"
FT   CHAIN           21..373
FT                   /note="Monocyte differentiation antigen CD14"
FT                   /id="PRO_0000020883"
FT   REPEAT          55..81
FT                   /note="LRR 1"
FT   REPEAT          82..117
FT                   /note="LRR 2"
FT   REPEAT          118..143
FT                   /note="LRR 3"
FT   REPEAT          144..171
FT                   /note="LRR 4"
FT   REPEAT          172..195
FT                   /note="LRR 5"
FT   REPEAT          196..223
FT                   /note="LRR 6"
FT   REPEAT          224..250
FT                   /note="LRR 7"
FT   REPEAT          251..276
FT                   /note="LRR 8"
FT   REPEAT          277..297
FT                   /note="LRR 9"
FT   REPEAT          298..319
FT                   /note="LRR 10"
FT   REPEAT          320..347
FT                   /note="LRR 11"
FT   REGION          288..373
FT                   /note="Required for response to bacterial
FT                   lipopolysaccharide (LPS)"
FT                   /evidence="ECO:0000250|UniProtKB:P10810"
FT   CARBOHYD        38
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        150
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        280
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        26..37
FT                   /evidence="ECO:0000250|UniProtKB:P08571"
FT   DISULFID        35..52
FT                   /evidence="ECO:0000250|UniProtKB:P08571"
FT   DISULFID        186..216
FT                   /evidence="ECO:0000250|UniProtKB:P08571"
FT   DISULFID        240..270
FT                   /evidence="ECO:0000250|UniProtKB:P08571"
FT   CONFLICT        209
FT                   /note="S -> T (in Ref. 2; AAD32215)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   373 AA;  39667 MW;  B9E9C2C51BE82227 CRC64;
     MVCVPYLLLL LLPSLLRVSA DTTEPCELDD DDFRCVCNFT DPKPDWSSAV QCMVAVEVEI
     SAGGRSLEQF LKGADTNPKQ YADTIKALRV RRLKLGAAQV PAQLLVAVLR ALGYSRLKEL
     TLEDLEVTGP TPPTPLEAAG PALTTLSLRN VSWTTGGAWL GELQQWLKPG LRVLNIAQAH
     SLAFPCAGLS TFEALTTLDL SDNPSLGDSG LMAALCPNKF PALQYLALRN AGMETPSGVC
     AALAAARVQP QSLDLSHNSL RVTAPGATRC VWPSALRSLN LSFAGLEQVP KGLPPKLSVL
     DLSCNKLSRE PRRDELPEVN DLTLDGNPFL DPGALQHQND PMISGVVPAC ARSALTMGVS
     GALALLQGAR GFA
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024